Literature DB >> 2694334

Surgical considerations for antireflux therapy.

R Siewert1, H Feussner.   

Abstract

Surgery has a major role to play in the treatment of reflux disease. Several factors should be considered prior to utilising the surgical approach. Severity of the reflux disease and response to conservative treatment are generally acceptable criteria for deciding whether a patient should undergo a surgical procedure. Once the decision is made to utilise a surgical approach, a specialised centre with an abundance of experienced, skilled surgeons and a specialised diagnostic laboratory should be selected. It is the responsibility of the referring physician and surgeon to diagnose accurately the presence of reflux disease. Endoscopy, pH-metry, and manometry are useful in precisely diagnosing the presence of reflux disease. Fundoplication is the favoured surgical procedure. The most common complications associated with this procedure are gas bloat and hypercontinence, which are acceptable tradeoffs for reflux disease. The patient must be educated about the surgical procedure and its consequences prior to the operation and informed of the alternatives. Accurate diagnosis, coupled with selection of an experienced surgeon and patient education can have a dramatic impact on reflux disease in the individual patient.

Entities:  

Mesh:

Year:  1989        PMID: 2694334

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  2 in total

Review 1.  Fundoplication: how to do it? Peri-esophageal wrapping as a therapeutic principal in gastro-esophageal reflux prevention.

Authors:  J R Siewert; H Feussner; S J Walker
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

Review 2.  A proposition for the diagnosis and treatment of gastro-oesophageal reflux disease in children: a report from a working group on gastro-oesophageal reflux disease. Working Group of the European Society of Paediatric Gastro-enterology and Nutrition (ESPGAN).

Authors:  Y Vandenplas; A Ashkenazi; D Belli; N Boige; J Bouquet; S Cadranel; J P Cezard; S Cucchiara; C Dupont; K Geboes
Journal:  Eur J Pediatr       Date:  1993-09       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.